| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |